Cart
sales@molnova.com
Resveratrol
CAS No. 501-36-0
Resveratrol ( (E)-Resveratrol )
Catalog No. M14685 CAS No. 501-36-0
Resveratrol is a phytoalexin produced naturally by several plants with anti-Y, anti-inflammatory, blood-sugar-lowering and other beneficial cardiovascular effects.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 27 | In Stock |
|
| 100MG | 32 | In Stock |
|
| 200MG | 45 | In Stock |
|
| 500MG | 68 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameResveratrol
-
NoteResearch use only, not for human use.
-
Brief DescriptionResveratrol is a phytoalexin produced naturally by several plants with anti-Y, anti-inflammatory, blood-sugar-lowering and other beneficial cardiovascular effects.
-
DescriptionResveratrol is a phytoalexin produced naturally by several plants with anti-Y, anti-inflammatory, blood-sugar-lowering and other beneficial cardiovascular effects.
-
Synonyms(E)-Resveratrol
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX-1; COX-2; DNA polymerase α; IKKβ; LOX; Quinone reductase 2; SIRT1; SIRT2
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number501-36-0
-
Formula Weight228.24
-
Molecular FormulaC14H12O3
-
Purity>98%(HPLC)
-
SolubilityDMSO: 45 mg/mL warmed (197.16 mM)
-
SMILESOC1=CC(/C=C/C2=CC=C(O)C=C2)=CC(O)=C1
-
Chemical Name(E)-5-(4-hydroxystyryl)benzene-1,3-diol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Pirola L, et al. IUBMB Life, 2008, 60(5), 323-332.
molnova catalog
related products
-
Flurbiprofen
A non-steroidal anti-inflammatory drug (NSAID); primarily indicated as a pre-operative anti-miotic as well as orally for arthritis or dental pain; cyclooxygenase (COX) inhibitor.
-
(S)-( )-Ibuprofen
An enantiomer of Ibuprofen that more potently inhibits COX activity, thromboxane formation, and platelet aggregation than the (R)-form.
-
Mollugin
Mollugin may be a JAK2 inhibitor and inhibits LPS-induced inflammatory responses by blocking the activation of the JAK-STAT pathway.
